STAT News
On Extra Extra, STAT News is grouped with center outlets, a placement drawn from the consensus of independent media-bias raters (AllSides, Ad Fontes Media, and Media Bias/Fact Check) rather than our own opinion. Its reliability rating of A reflects a strong track record of factual, well-sourced reporting. That rating is a guide for weighing what you read here, not a verdict on any single article.
We are currently tracking 8 recent articles from STAT News, published over the past 12 hours. Recurring themes in its latest headlines include Stat.
The best way to use this profile is comparatively. Read STAT News's coverage of a story alongside how outlets on other parts of the spectrum handle the same event — the facts usually overlap, but the emphasis, language, and what gets left out often do not. Other center sources we track include BBC News, Al Jazeera, Associated Press, and Reuters.
Recent Articles (8)
FDA still focused on lettuce supplier as source of parasite, despite faulty test result
The FDA said Monday it is still focused on lettuce from Taylor Farms as the source of a multistate outbreak of a diarrhea-causing parasite, despite a faulty test result.
STAT+: The next step of site-neutral, and a fiery PBM hearing
Medicare proposes to reduce payments to hospitals for certain drugs and imaging services.
STAT+: A most-wanted fugitive appears to have been secretly working as a biotech executive
A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech executive.
STAT+: Pharmalittle: We’re reading about a telehealth firm and patient safety, PBMs overcharging, and more
Some former employees say telehealth company LifeMD has sought to maximize the volume of GLP-1 prescriptions at the expense of patient safety
HHS vaccine committee quietly gets new charter
Lax clinical oversight for online GLP-1 prescriptions, proposed financial help for people who want to quit smoking, and more health news
STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life sciences industry.
Opinion: It’s time to treat pandemics as threats to national security
“Pandemics should be viewed and combated as threats to national security,” write David Blumenthal and James A. Morone.
STAT+: State audit of Medicaid records points to methods used by PBMs to obscure drug costs
An audit of state Medicaid records revealed how PBMs are using complicated tactics for handling prescription drug claims that ultimately overcharge taxpayers.